Kyverna Therapeutics, Inc.
SEC Filing List
CIK: 0001994702
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| 144 | Filing for proposed sale of securities u... | Morgan Stanley Smith Barney LLC Executive Services /FA | 04/07/2026 | ||
| 424B5 | Prospectus filed pursuant to Rule 424(b)(5) | Kyverna Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/02/2026 | |
| EFFECT | Effectiveness refer to a Registration St... | cik 9999999995 /fa | 04/02/2026 | ||
| 144 | Filing for proposed sale of securities u... | Morgan Stanley Smith Barney LLC Executive Services /FA | 03/31/2026 | ||
| 8-K | Current report filing | Kyverna Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 03/26/2026 | |
| S-3 | Registration statement for specified tra... | Kyverna Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 03/26/2026 | |
| S-8 | Initial registration statement for secur... | Kyverna Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 03/26/2026 | |
| 10-K | Annual report pursuant to Section 13 and... | Kyverna Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 03/26/2026 | |
| 4 | Statement of changes in beneficial owner... | Grasso Marc | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 03/17/2026 | |
| 4 | Statement of changes in beneficial owner... | Miller Andrew Craig | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 03/04/2026 | |
| No record found. | |||||
| Load More | |||||
